Dogwood Therapeutics DWTX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's EPS (diluted)?
- Dogwood Therapeutics (DWTX) reported EPS (diluted) of -$0.15 in Q1 2026.
- How has Dogwood Therapeutics's EPS (diluted) changed year-over-year?
- Dogwood Therapeutics's EPS (diluted) increased by 98.2% year-over-year, from -$8.45 to -$0.15.
- What is the long-term trend for Dogwood Therapeutics's EPS (diluted)?
- Over 3 years (2021 to 2024), Dogwood Therapeutics's EPS (diluted) has grown at a 86.5% compound annual growth rate (CAGR), from -$1.92 to -$12.45.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.